[SCHEDULE 13G/A] OptiNose, Inc. SEC Filing
OptiNose, Inc. filing discloses that Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon report beneficial ownership of 0 common shares (0.0%) of OptiNose common stock. The filing lists no sole or shared voting power and no sole or shared dispositive power for any reporting person.
The statement identifies Rosalind Advisors as an adviser and Salamon and Aharon as portfolio managers and includes a certification that the securities are held in the ordinary course of business and were not acquired to influence control; ownership is reported as 5% or less.
- Transparent disclosure showing 0 shares (0.0%) beneficial ownership by the reporting persons
- Certification included that securities are held in the ordinary course and not to influence control
- No voting or dispositive power reported by the filers — they hold 0 shares (0.0%)
Insights
TL;DR: Reporting parties disclose zero ownership and no voting or dispositive power; impact on equity holders is neutral.
The Schedule 13G/A shows 0 shares (0.0%) beneficially owned by Rosalind Advisors, Rosalind Master Fund, Steven Salamon and Gilad Aharon. All entries for sole and shared voting and dispositive power are zero and the filing indicates ownership of 5% or less. This is a routine disclosure from an adviser and portfolio managers; it confirms no equity stake or control intent from the named parties.
TL;DR: No reported stake and an explicit certification that holdings are not for control; no governance influence from these filers.
The document identifies the reporting parties and their roles and certifies that the securities are held in the ordinary course and not to change or influence control. With 0 shares (0.0%) and no voting/dispositive power recorded, there is no material governance impact from these entities or individuals based on this filing.